Skip to content

Clinical trials

Lung Neoplasms trials in Hong Kong with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Not applicable Country / region: Hong Kong Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20191
20202
20211
20224
20231
20244
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed5
Unknown status4
Terminated3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong9
Chinese University of Hong Kong4
Galvanize Therapeutics, Inc.2
Broncus Medical Inc1
Ensemble Group Holdings, LLC1
Ethicon, Inc.1
Nam Dinh University of Nursing1
Noah Medical1
Tianjin Puli Ark Medical Technology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung2
Fatigue2
Anxiety Disorders1
Chronic Disease1
Colorectal Neoplasms1
Cough1
Disease1
Dyspnea1
Pleural Effusion, Malignant1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.